Cost-Effectiveness of Rivaroxaban in the Prevention of Stroke in Non-Valvular Atrial Fibrillation Patients in Italy
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1279
https://www.valueinhealthjournal.com/article/S1098-3015(13)03184-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1128
First Page :
A525
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03184-7&doi=10.1016/j.jval.2013.08.1279